Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $48.2B |
| FY2017, ended Dec 31, 2017 | $49.6B |
| FY2018, ended Dec 31, 2018 | $30.4B |
| FY2019, ended Dec 31, 2019 | $36.9B |
| FY2020, ended Dec 31, 2020 | $35.0B |
| FY2021, ended Dec 31, 2021 | $83.2B |
| FY2022, ended Dec 31, 2022 | $46.4B |
| FY2023, ended Dec 31, 2023 | $48.4B |
| FY2024, ended Dec 31, 2024 | $39.2B |
| FY2025, ended Dec 31, 2025 | $52.3B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $46.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $152B |
| FY2017, ended Dec 31, 2017 | $157B |
| FY2018, ended Dec 31, 2018 | $160B |
| FY2019, ended Dec 31, 2019 | $156B |
| FY2020, ended Dec 31, 2020 | $127B |
| FY2021, ended Dec 31, 2021 | $136B |
| FY2022, ended Dec 31, 2022 | $158B |
| FY2023, ended Dec 31, 2023 | $176B |
| FY2024, ended Dec 31, 2024 | $185B |
| FY2025, ended Dec 31, 2025 | $187B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $190B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.59B | $12.9B |
| FY2017, ended Dec 31, 2017 | $7.73B | $11.0B |
| FY2018, ended Dec 31, 2018 | $3.68B | $7.24B |
| FY2019, ended Dec 31, 2019 | $47.0M | $10.0B |
| FY2020, ended Dec 31, 2020 | −$1.28B | $18.5B |
| FY2021, ended Dec 31, 2021 | $17.9B | $9.56B |
| FY2022, ended Dec 31, 2022 | −$1.98B | −$13.0M |
| FY2023, ended Dec 31, 2023 | $4.35B | $6.68B |
| FY2024, ended Dec 31, 2024 | $5.88B | $6.74B |
| FY2025, ended Dec 31, 2025 | −$8.18B | $12.5B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | −$6.11B | $9.55B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.9B |
| FY2017, ended Dec 31, 2017 | $18.5B |
| FY2018, ended Dec 31, 2018 | $16.7B |
| FY2019, ended Dec 31, 2019 | $17.5B |
| FY2020, ended Dec 31, 2020 | $25.2B |
| FY2021, ended Dec 31, 2021 | $20.5B |
| FY2022, ended Dec 31, 2022 | $25.1B |
| FY2023, ended Dec 31, 2023 | $24.9B |
| FY2024, ended Dec 31, 2024 | $22.9B |
| FY2025, ended Dec 31, 2025 | $23.4B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $17.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | $600M |
| FY2019, ended Dec 31, 2019 | $470M |
| FY2020, ended Dec 31, 2020 | $291M |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 3.97B |
| FY2017, ended Dec 31, 2017 | 3.97B |
| FY2018, ended Dec 31, 2018 | 3.98B |
| FY2019, ended Dec 31, 2019 | 3.96B |
| FY2020, ended Dec 31, 2020 | 3.98B |
| FY2021, ended Dec 31, 2021 | 4.00B |
| FY2022, ended Dec 31, 2022 | 3.99B |
| FY2023, ended Dec 31, 2023 | 3.97B |
| FY2024, ended Dec 31, 2024 | 3.96B |
| FY2025, ended Dec 31, 2025 | 3.99B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 3.98B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $145M | $210M |
| FY2017, ended Dec 31, 2017 | $131M | $246M |
| FY2018, ended Dec 31, 2018 | $164M | $191M |
| FY2019, ended Dec 31, 2019 | $237M | $228M |
| FY2020, ended Dec 31, 2020 | $0 | $199M |
| FY2021, ended Dec 31, 2021 | $0 | $305M |
| FY2022, ended Dec 31, 2022 | $484M | $336M |
| FY2023, ended Dec 31, 2023 | $335M | $460M |
| FY2024, ended Dec 31, 2024 | $426M | $511M |
| FY2025, ended Dec 31, 2025 | $0 | $510M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $311M | $499M |
Valuation
At current price- Market Cap
- $46.7B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.2×
- Price / Book
- 1.2×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $190B
- Revenue Growth YoY
- 3.8%
- Revenue CAGR 3Y
- 5.8%
- Revenue CAGR 5Y
- 8.1%
- EPS Growth YoY
- −224%
- Net Income Growth YoY
- −222%
Profitability
Trailing 12 months- Gross Margin
- 8.0%
- Operating Margin
- −3.8%
- Net Margin
- −3.2%
- FCF Margin
- 5.0%
- Return on Equity
- −14.9%
Earnings
Trailing 12 months- Net Income
- −$6.11B
- EPS (diluted)
- −$1.55
- EBITDA
- $8.85B
- Operating Income
- −$7.16B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $17.6B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $282B
- Total Liabilities
- $245B
- Shareholders' Equity
- $37.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $18.9B
- Capital Expenditure
- $9.37B
- Free Cash Flow
- $9.55B
Dividends and risk
Last 12 months- Dividend Yield
- 5.1%
- Dividend / Share
- $0.60
- Beta (5Y)
- 1.93
Every ratio is calculated from the company’s reported figures.